Cystic Fibrosis Care Gets a Makeover

Cystic fibrosis is a genetic condition that affects multiple systems in the body. Thanks to advancements in CF modulator therapies, people with the condition are living longer and healthier lives. A team of healthcare providers and patients worked together to create a new model of care that focuses on endocrine and metabolic health. This new approach, called CF Endocrine, aims to address the unique needs of adults with cystic fibrosis.

The team used a combination of surveys, audits, and workshops to identify the top priorities for patients and healthcare providers. They found that adults with cystic fibrosis are most concerned about optimizing their lifestyle, managing their weight, and preventing diabetes. These concerns led to the development of four key service areas: diabetes support, bone health, metabolic health, and reproductive/sexual health.

Healthcare providers are on board with the new model of care, and patients are likely to benefit from the more comprehensive approach. By integrating these services, patients will receive more coordinated and personalized care. This is especially important as people with cystic fibrosis are living longer and facing new challenges related to their condition.

The CF Endocrine service is designed to be flexible and adaptable, allowing it to evolve as the needs of patients change. By working together, patients and healthcare providers can ensure that adults with cystic fibrosis receive the best possible care. This new model of care has the potential to improve health outcomes and quality of life for people with cystic fibrosis.

The development of CF Endocrine is a step forward in the post-modulator era, where the focus is on optimizing care and addressing emerging gaps in services. By prioritizing patient needs and provider concerns, this new model of care can make a real difference in the lives of adults with cystic fibrosis.